T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Workiva
WK
$4.01B
| $90.4M | 0.01% |
1,047,893
-443,530
| -30% | -$39.3M |
|
652
Centrus Energy
LEU
$3.83B
| $90.3M | 0.01% |
371,822
+207,316
| +126% | +$62.6M |
|
653
Humana
HUM
$46.2B
| $90M | 0.01% |
351,477
-107,023
| -23% | -$28.1M |
|
654
American Electric Power
AEP
$68.3B
| $89.8M | 0.01% |
779,005
+1,606
| +0.2% | +$190K |
|
655
FTI Consulting
FCN
$4.24B
| $89.8M | 0.01% |
525,577
+13,840
| +3% | +$2.28M |
|
656
iRhythm Holdings
IRTC
$4.06B
| $89.1M | 0.01% |
502,120
+162,479
| +48% | +$28.8M |
|
657
Fulton Financial
FULT
$4.69B
| $88.7M | 0.01% |
4,590,883
+1,054,321
| +30% | +$19.4M |
|
|
P
658
Everpure Inc
P
$39B
| $88.6M | 0.01% |
1,322,584
-29,768
| -2% | -$2.49M |
|
659
PennyMac Financial
PFSI
$4.13B
| $88.5M | 0.01% |
671,025
-20,213
| -3% | -$2.58M |
|
660
Aflac
AFL
$60.7B
| $88.4M | 0.01% |
801,657
-23,205
| -3% | -$2.56M |
|
661
MP Materials
MP
$9.91B
| $88M | 0.01% |
1,742,675
-1,723,438
| -50% | -$109M |
|
|
ABVX
662
Abivax
ABVX
$10.6B
| $87.9M | 0.01% |
651,644
+171,775
| +36% | +$18.7M |
|
663
T. Rowe Price Blue Chip Growth ETF
TCHP
$2.22B
| $87.8M | 0.01% |
1,760,001
+250,000
| +17% | +$12.4M |
|
664
Steris
STE
$23B
| $87.6M | 0.01% |
345,517
+88,416
| +34% | +$22.2M |
|
665
Camden Property Trust
CPT
$11.1B
| $87.2M | 0.01% |
791,986
-33,580
| -4% | -$3.49M |
|
666
Kodiak Gas Services
KGS
$6.3B
| $86.9M | 0.01% |
2,323,602
-79,409
| -3% | -$2.81M |
|
667
Microchip Technology
MCHP
$42.2B
| $86.7M | 0.01% |
1,359,860
-881,456
| -39% | -$54.4M |
|
|
CRCL
668
Circle Internet Group
CRCL
$19.1B
| $86.4M | 0.01% |
1,089,558
+671,078
| +160% | +$69.4M |
|
669
Target
TGT
$70.6B
| $85.2M | 0.01% |
871,131
+200,093
| +30% | +$18.4M |
|
670
Domino's
DPZ
$11.6B
| $83.9M | 0.01% |
201,353
+3,115
| +2% | +$1.3M |
|
671
Manhattan Associates
MANH
$11.7B
| $83.5M | 0.01% |
481,947
-101,099
| -17% | -$18.5M |
|
672
Alcoa
AA
$13.1B
| $83.4M | 0.01% |
1,569,328
-68,343
| -4% | -$2.8M |
|
673
United Rentals
URI
$69.7B
| $83.4M | 0.01% |
103,019
+321
| +0.3% | +$279K |
|
674
Global Payments
GPN
$25.1B
| $83.1M | 0.01% |
1,073,172
-96,372
| -8% | -$7.76M |
|
675
Air Products & Chemicals
APD
$68B
| $81.5M | 0.01% |
330,125
+1,767
| +0.5% | +$448K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.